Clinical Trials Directory

Trials / Completed

CompletedNCT03831750

Assessing the Effectiveness of a Stress Reduction Intervention in Inflammatory Bowel Disease (IBD)

Assessing the Effectiveness of a Stress Reduction Intervention in Inflammatory Bowel Disease (IBD): a Prospective Randomized Controlled Trial (RCT)

Status
Completed
Phase
N/A
Study type
Interventional
Enrollment
101 (actual)
Sponsor
University of Alberta · Academic / Other
Sex
All
Age
18 Years – 90 Years
Healthy volunteers
Not accepted

Summary

The investigators have designed a guided, online, tri-component, stress reduction intervention for participants with inflammatory bowel diseases.

Detailed description

In a randomized controlled trial, the investigators assessed the impact of an online, 3-month stress reduction intervention (yoga, breathwork, and meditation). The primary outcome was the change in Cohen's Perceived Stress Scale (PSS) between the control and intervention arms. The following secondary outcomes were also assessed: anxiety, depression, IBD disease activity (e.g., changes in CRP, fecal calprotectin, medication, hospitalization, or surgery), serum inflammatory markers, serum and salivary markers of stress, stress-resilience, and health- related quality of life. Participant satisfaction and adherence to the intervention were also evaluated.

Conditions

Interventions

TypeNameDescription
OTHERStress Reduction InterventionThe tri-component intervention is comprised of guided videos for breath-work (5-15 min), stretching (5-15 min), and meditation (10-30 min). The intervention will be delivered online via an access restricted website.

Timeline

Start date
2019-02-22
Primary completion
2020-03-01
Completion
2021-01-15
First posted
2019-02-06
Last updated
2021-05-13

Locations

1 site across 1 country: Canada

Source: ClinicalTrials.gov record NCT03831750. Inclusion in this directory is not an endorsement.